Back to today’s briefing

Story perspectives

Experts Recommend Non-Opiate Fibromyalgia Treatments Over Propoxyphene

2/5/2025

50 12

Summary

Story summary

In 2010, Propoxyphene (Darvon) was pulled from the market over alarming heart toxicity concerns, even as some patients praised its effectiveness. For fibromyalgia, experts advocate for non-opiate alternatives. Meanwhile, Dr. Roach highlights surprising dietary choices, noting that a 12-ounce soda can be a better option than a sugary, fatty 4-ounce Irish cream liqueur.

1 of 1

Story summary

In 2010, Propoxyphene (Darvon) was pulled from the market over alarming heart toxicity concerns, even as some patients praised its effectiveness. For fibromyalgia, experts advocate for non-opiate alternatives. Meanwhile, Dr. Roach highlights surprising dietary choices, noting that a 12-ounce soda can be a better option than a sugary, fatty 4-ounce Irish cream liqueur.